ãç¬ã£ãŠããªããŠãã»ãããç·ãæ°ã«ãªãã¯ãããŸããã
以åã¯æºé¢ã«ç¬ã£ããšãã ãäžç¬çŸããŠããã»ãããç·ãããã€ã®éã«ãç¡è¡šæ ã®ãšããå»ãŸããŠããã®ã«æ°ã¥ããšãè€éãªæ°æã¡ã«ãªããŸããããCelliniqueïŒã»ãªããã¯å»é¢ïŒã®ã«ãŠã³ã»ãªã³ã°ã§ãããã»ãããç·ãç®ç«ããªãããã«ã¯ã©ãããã°ããã§ããããšããã質åããšãŠãå€ãããã ããŸãã
æ¬æ¥ã¯ãæ±å島山倧路ïŒããµã³ããïŒã«äœçœ®ããã»ãªããã¯å»é¢ïŒCelliniqueïŒã®éå¥å®é¢é·ããã»ãããç·ããªãçããã®ããšããã¡ã«ããºã ãããã±ã¢ã»æœè¡ã®éžæè¢ããããŠãèªèº«ã«åã£ãæ¹åæ§ãã©ã®ããã«éžã¶ããŸã§ãäžå¯§ã«ã説æããŸããç¹å®ã®æœè¡ãäžæã§å§ããå 容ã§ã¯ãªããã»ãããç·ãšãããæ©ã¿ãã©ã®ãããªåºæºã§è§£æ±ºããŠãããã«çŠç¹ãåœãŠãŠããŸãã
3è¡ãŸãšã
1. ã»ãããç·ã¯äžã€ã®åå ã§ã¯ãªããçç®ã³ã©ãŒã²ã³ã®æžå°ã»äžé¡é¢èèªå±€ã®åãäžããã»äžé¡éªšã®åžåãšãã£ãè€æ°ã®å±€ã®èåãéãªã£ãŠæ·±ããªããŸããããç ç©¶ã§ã¯ã20代ãš30代ã®ããã ã§çºã®é·ããçŽ2.8åã®å·®ãããããšãå ±åãããŠããŸãã
2. ã±ã¢ã®éžæè¢ã¯å€§ãããã£ã©ãŒïŒããªã¥ãŒã è£å©ïŒã»ã³ã©ãŒã²ã³åºæ¿æœè¡ã»ã¹ãã³ããŒã¹ã¿ãŒã»ãªããã£ã³ã°ã®4ã€ã«åãããåå ã«å¿ããŠçµã¿åãããç°ãªããŸãã
3. å¹æã»æç¶æéã¯å人差ã倧ãããå¯äœçšã®å¯èœæ§ãããããããå®å šã«ãªããããšãã衚çŸããããåå ã«åãããæ¹åãžã®ã¢ãããŒãããæ£ç¢ºã§ããäºåã«ãŠã³ã»ãªã³ã°ã§åå¥ã«è©äŸ¡ããŸãã
1. ã»ãããç·ã¯ãªãçããã®ãïŒ â äžã€ã®å±€ã§ã¯ãªããè€æ°ã®å±€ã®åé¡
ã»ãããç·ïŒéŒ»åæºãnasolabial foldïŒã¯ãéŒ»ã®æšªããå£è§ãžãšç¶ãã·ã¯ã§ããå€ãã®æ¹ããèãèåããããã§ããããšãèãã«ãªããŸãããå®éã«ã¯ç®è衚é¢ã®äžå±€ã ãã§ãªããè€æ°ã®å±€ã®å€åãè€åçã«äœçšããŠæ·±ããªããŸãã
- çç®ã³ã©ãŒã²ã³ã»ç®èã®åã¿ã®æžå° â å 霢ãšãšãã«çç®ã®ã³ã©ãŒã²ã³ãç®èã®åã¿ãåŸã ã«æžå°ããã·ã¯ãå®çããããåå°ã圢æãããŸãã
- äžé¡é¢èèªå±€ã®åãäžãã â é ¬ïŒãã©ãŒã»é ¬éªšäžïŒã®èèªå±€ãéåãæ¯æçµç¹ã®è¡°ãã«ãã£ãŠäžæ¹ãžç§»åããããšã§ãéŒ»ã®æšªã«çããããŒã¿ãããç®ç«ã€ããã«ãªããŸãã
- äžé¡éªšã®åžå â äžé¡é¢ã®éªšæ Œããšãã«äžé¡éªšãå 霢ã«äŒŽã£ãŠåžåããããšããã®äžã«ä¹ãè»éšçµç¹ãæ¯ããåã匱ãŸããã»ãããç·ãããæ·±ãèŠããããšããããŸãã
- å èåã»çæŽ»ç¿æ £ â 玫å€ç·ã®èç©ãå«ç ãç¡ç äžè¶³ãªã©ããã³ã©ãŒã²ã³æ§é ã«åœ±é¿ããããšãç¥ãããŠããŸãã
ãã®ãããåããã»ãããç·ã®ãæ©ã¿ãã§ããäž»ã«ããªã¥ãŒã ã倱ãããåé¡ã®æ¹ãåãäžããã®æ¯éã倧ããæ¹ãèã®ãã¡ã»ã³ã©ãŒã²ã³ãå ã«æ°ã«ãªãæ¹ãšããããã«ãç¶æ³ã¯ããããç°ãªããŸããååã«ãŠã³ã»ãªã³ã°ã§ãäœããããããæ±ºããåã«ãã©ã®è»žãåªå ããŠèŠãã¹ããããäžç·ã«æŽçããçç±ãããã«ãããŸãã
ð¡ ãã¡ã¯ããã§ã㯠â
åºå žïŒAesthetic Surgery Journal Open Forum 2025 (PMC12322485)
- ã»ãããç·ã¯ãçç®ã³ã©ãŒã²ã³ã»ç®èã®åã¿ã®æžå°ãäžé¡é¢èèªå±€ïŒãã©ãŒã»é ¬éªšäžèèªïŒã®åãäžãããäžé¡éªšãå«ãäžé¡é¢éªšæ Œã®åžåãè€åçã«äœçšããŠæ·±ããªãããšãå ±åãããŠããŸãã
- åç ç©¶ã«ãããŠã20代ãš30代ã®ããã ã§çºã®é·ããçŽ2.81åã®å·®ããããäžéšã¯30ã50代ã«ãããŠåŸã ã«ãäžéšã¯40ã70代ã«ãããŠé¡èã«å€åããåŸåãå ±åãããŠããŸãã
- ãã ããå€åã®çšåºŠã»é床ã¯å人ã®éºäŒçèæ¯ã»ç掻ãã¿ãŒã³ã«ãã£ãŠç°ãªããŸãã
2. ããªãããã§ã¯ãªããåå ã«åãããŠã¢ãããŒãããã
ãŸãççŽã«ãäŒãããŸããã»ãããç·ããå®å šã«ãªããããšæèšããããšã¯é£ããã®ãçŸå®ã§ããå 霢ã«äŒŽãèªç¶ãªæ§é å€åãã®ãã®ããŒãã«æ»ãããšã¯ã§ããŸããããã ããåå ãåããŠæŽçããããããã«åã£ãæ¹æ³ãçµã¿åãããããšã§ãã·ã¯ãæ·±ãèŠããçšåºŠãäœæãžã®ã¢ãããŒãã¯å¯èœã§ãã
ãã®ããCelliniqueã§ã¯ããã»ãããç·ïŒå¿ ããã£ã©ãŒããšããäžã€ã®çãã§å¯Ÿå¿ããããšã¯ãããŸãããããªã¥ãŒã ã倱ãããæ¹ã«èã®ãã¡ã ããæŽããæœè¡ãææ¡ããããåãäžããã倧ããæ¹ã«ããªã¥ãŒã ã®ã¿ãè£å ããããããšãçµæã®å®å®æ§ãæºè¶³åºŠã«å·®ãçããããšãããããã§ãã
3. ã±ã¢ã»æœè¡ã®éžæè¢4ã€ïŒã»ãªããã¯å»é¢ã»Cellinique æäŸç¯å²å ïŒ
ã»ãããç·ã®ã±ã¢ã¯ã倧ãã以äžã®4ã€ã®æ¹åæ§ã§ãèãããã ããŸããã©ããäžæ¹ã ããéžã¶ãšãããããåå ã«å¿ããŠçµã¿åãããã®ãäžè¬çã§ãã
A) ãã£ã©ãŒ â 倱ãããããªã¥ãŒã ãçŽæ¥è£å©
ãã¢ã«ãã³é žïŒHA, hyaluronic acidïŒãã£ã©ãŒã¯ãããŒãã éšåã«ããªã¥ãŒã ãè£ããã·ã¯ãæã蟌ãçšåºŠã軜æžããæ¹åæ§ã§ããã»ãããç·é åã§æãå€ãç ç©¶ãããŠããéžæè¢ã®äžã€ã§ãèšåºçæ ¹æ ãæ¯èŒçè±å¯ã§ãããã ããå¹æã»æç¶æéã¯è£œåã»æ³šå ¥éã»å人ã®ç¶æ ã«ãã£ãŠå·®ããããæµ®è «ã»å åºè¡ã»çµç¯ãªã©ã®åå¿ãçããå¯èœæ§ããããŸãã
ð¡ ãã¡ã¯ããã§ã㯠â
åºå žïŒAesthetic Plastic Surgery 2018 (PMID 29740661) · Aesthetic Surgery Journal Open Forum 2025 (PMC12322485)
- ã»ãããç·ãžã®ãã¢ã«ãã³é žïŒHAïŒãã£ã©ãŒã«ã€ããŠã¯ã12ä»¶ã®ç¡äœçºåå¯Ÿç §è©Šéšã»æ£è 908åãçµ±åããã·ã¹ãããã£ãã¯ã¬ãã¥ãŒã»ã¡ã¿åæã«ãããŠãç¯æ£å¹æãšå®å šæ§ãå ±åãããŠããŸãïŒAesthetic Plastic Surgery, PMID 29740661ïŒã
- ååæã«ãããŠããªãã«ã€ã³ãé åããHAã¯æ³šå ¥æã®çŒç軜æžã«æå©ã§ãããç¯æ£å¹æã»å®å šæ§ã¯ãªãã«ã€ã³å«æã®æç¡ã«ãããåçæ°Žæºãšå ±åãããŸãããæµ®è «ã»çŽ æã»å åºè¡ã»æ»çã»ç¡¬çµãªã©ã®åå¿ã¯äž¡çŸ€éã§ææå·®ã¯èªããããŸããã§ããã
- å¹æã»æç¶æéã¯è£œåã»æ³šå ¥éã»å人差ãããããèªèº«ã«é©ããéžæè¢ã¯äºåã«ãŠã³ã»ãªã³ã°ã«ãŠã確èªãã ããã
B) ã³ã©ãŒã²ã³åºæ¿ã®æ¹åæ§ â æéããããŠåå°ãæŽãã
ç®èã®ã³ã©ãŒã²ã³ç£çãä¿ãæ¹åæ§ã®ã¢ãããŒãã§ããCelliniqueã§åãæ±ããžã¥ãã«ãã¯ïŒJuvelookïŒãªã©ã®éžæè¢ãããã«è©²åœããŸãããžã¥ãã«ãã¯ã¯PDLLAïŒããª-D,L-ä¹³é žïŒãšéæ¶æ©ãã¢ã«ãã³é žãé åããæåã§ãèªå·±ã³ã©ãŒã²ã³ç£çããµããŒããããšãããŠããŸããããã«è£å ããæ¹åŒã§ã¯ãªããæéããããŠæ®µéçã«äœæããçµæã§ãããããé·æçãªç®¡çã®èгç¹ã§ãæ€èšã®æ¹ã«èæ ®ãããŸãã
ð¡ ãã¡ã¯ããã§ã㯠â
åºå žïŒéåœé£åå»è¬åå®å šåŠïŒMFDSïŒçµç¹ä¿®åŸ©çšçäœææ åé¡ã»åœå èš±å¯ Â· CE · ãã€ã ã°ããŒãã«ïŒVaim Globalã補é å ïŒ
- ãžã¥ãã«ãã¯ã¯PDLLAïŒéæ¶æ©ãã¢ã«ãã³é žïŒHAïŒæåã§ãéåœé£åå»è¬åå®å šåŠïŒMFDSïŒã®ãçµç¹ä¿®åŸ©çšçäœææãåé¡ã«ãããåœå èš±å¯ïŒæ¬§å·CEã確èªãããŠããŸãïŒè£œé å ïŒãã€ã ã°ããŒãã«ãVaim GlobalïŒã
- ç±³åœFDAã®æ¿èªå®çžŸã¯ç¢ºèªãããŠããªããããåœå MFDSèš±å¯ã»CEã®ç¯å²ã®ã¿ãæ¡å ããŠããŸãã
- ã³ã©ãŒã²ã³ç£çãä¿ãæœè¡ã¯å¹æã段éçã§å人差ã倧ãããªããŸãã
C) ã¹ãã³ããŒã¹ã¿ãŒ â ãã¡ã»æ°Žåã®åå°ãè£å©
ã»ãããç·åšå²ã®èã®ãã¡ã»æ°Žåã»åŒŸåã®åå°ããµããŒãããæ¹åæ§ã§ããCelliniqueã§åãæ±ããªãžã¥ã©ã³ïŒRejuranïŒã¯ãµãŒã¢ã³DNAã«ç±æ¥ããPNïŒããªãã¯ã¬ãªããïŒæåãããŒã¹ã«ãéåœé£åå»è¬åå®å šåŠïŒMFDSïŒã®å»çæ©åšèš±å¯ãååŸããçµç¹ä¿®åŸ©çšçäœææã§ããã»ãããç·ãã®ãã®ãè£å ããæœè¡ãšããããããåšå²ã®èã³ã³ãã£ã·ã§ã³ãåãããŠæŽããè£å©è»žãšããŠçµã¿åãããããããšãå€ãã§ãã
ð¡ ãã¡ã¯ããã§ã㯠â
åºå žïŒéåœé£åå»è¬åå®å šåŠïŒMFDSïŒå»çæ©åšåç®èš±å¯ïŒèš±å¯çªå· 14-825ã2014幎ããããªãµãŒããPharmaResearchïŒ
- ãªãžã¥ã©ã³ã¯PNïŒããªãã¯ã¬ãªããããµãŒã¢ã³DNAç±æ¥ïŒ20mg/mLæåã§ãéåœé£åå»è¬åå®å šåŠïŒMFDSïŒå»çæ©åšèš±å¯ïŒèš±å¯çªå· 14-825ã2014幎ããããªãµãŒããPharmaResearchïŒãååŸããçµç¹ä¿®åŸ©çšçäœææã§ãã
- éšäœã»å€åœ¢ã«ãã£ãŠéžæè¢ãåãããããããèªèº«ã«åã£ãå€åœ¢ã¯äºåã«ãŠã³ã»ãªã³ã°ã«ãŠã確èªãã ããã
- ãã¡ã»æ°Žåã»åŒŸåã®äœæã«ã¯å人差ããããŸãã
D) ãªããã£ã³ã°ã®æ¹åæ§ â åãäžããã®è»žãè£å©
é ¬ã»äžé¡é¢ã®åãäžãããã»ãããç·ã®å€§ããªèŠå ãšãªã£ãŠããå Žåãåããçµç¹ãåŒãäžãããªããã£ã³ã°ã®æ¹åæ§ãåãããŠãæ€èšããã ãããšããããŸããããªã¥ãŒã ãè£ãæ¹åæ§ãšã¯æ§è³ªãç°ãªãããããããŒã¿ã®åé¡ãªã®ããåãäžããã®åé¡ãªã®ãããå ã«åºå¥ããããšãéèŠã§ããã©ã®æ¹åŒããèªèº«ã«åããã¯ãäºåè©äŸ¡ãå¿ èŠã§ãã
4. äžèЧã§ç¢ºèªïŒéžæè¢å¥ã®ç¹åŸŽ
| æ¹åæ§ | äž»ã«ã¢ãããŒãããåå | äœæã®åŸå | æ€èšãããç¶æ³ã®äŸ |
|---|---|---|---|
| ãã£ã©ãŒïŒHAïŒ | ããªã¥ãŒã åªå€±ã«ããããŒã¿ | æ¯èŒçæ©æã®ããªã¥ãŒã è£å© | ããŒã¿ãæ·±ãæããå Žå |
| ã³ã©ãŒã²ã³åºæ¿ïŒãžã¥ãã«ãã¯çïŒ | çç®ã³ã©ãŒã²ã³ã»èã®åå° | æéããããŠæ®µéçã« | é·æçãªç®¡çãåžæããå Žå |
| ã¹ãã³ããŒã¹ã¿ãŒïŒãªãžã¥ã©ã³çïŒ | åšå²ã®ãã¡ã»æ°Žåã»åŒŸå | ãã¡ã»ã³ã³ãã£ã·ã§ã³ã®è£å© | åšå²ã®èã也ç¥ã»ææãªå Žå |
| ãªããã£ã³ã°ã®æ¹åæ§ | äžé¡é¢ã®åãäžãã | 茪éã»åãäžããã®è£å© | é ¬ã®åãã§ããŒã¿ãæ·±ãèŠããå Žå |
â» äžè¡šã¯äžè¬çãªãæ¡å ã§ãããå®éã«ã©ã®æ¹åæ§ããèªèº«ã«åããã¯äºåã«ãŠã³ã»ãªã³ã°ã«ãŠåå¥ã«è©äŸ¡ããŸããå ·äœçãªæœè¡åã»çµã¿åããã¯ã«ãŠã³ã»ãªã³ã°ã®æ®µéã§ãæ¡å ããŸãã
5. ãèªèº«ã«åã£ãæ¹åæ§ã®éžã³æ¹
ã»ãããç·ã®ã«ãŠã³ã»ãªã³ã°ã«ãè¶ãããã ããšãCelliniqueã§ã¯é垞以äžã®é ç®ãäžç·ã«æŽçããŸããããããæŽçãããªããŸãŸæœè¡ãéå§ãããšãçµæã®å®å®æ§ãæºè¶³åºŠã«å·®ãçããããšãããããã§ãã
- äž»ãªåå ã®åºå¥ â ããªã¥ãŒã ã®åªå€±ããåãäžããããèã®ãã¡ã»ã³ã©ãŒã²ã³ã
- æ¢åŸã®æœè¡æŽ â ãããŸã§ã®ãã£ã©ãŒã»ãªããã£ã³ã°ã»ã¹ãã³ããŒã¹ã¿ãŒã®æœè¡æŽãšå埩ãã¿ãŒã³
- çæŽ»ãã¿ãŒã³ â 玫å€ç·æé²ã»ç¡ç ã»å«ç ã»ã¹ãã¬ã¹
- å¥åº·ç¶æ ãšæ¢åŸæŽ â ã¢ã¬ã«ã®ãŒã»è¡æ¶²çŸæ£ã»èªå·±å ç«çŸæ£ã»æçšäžã®è¬
- ã±ã¢ã®ç®æšãšããŠã³ã¿ã€ã â çæçãªæ¹åéèŠãé·æçãªç®¡çéèŠãã蚱容ã§ããããŠã³ã¿ã€ã
ãã®æµãã®äžã§ãéå¥å®é¢é·ããèªèº«ã«åã£ãæ¹åæ§ãšåªå é äœãäžç·ã«æŽçããŸããèã®èåã®è©³ããããã»ã¹ã«ã€ããŠç¥ãããæ¹ã¯ã¢ã³ããšã€ãžã³ã°ç·åã¬ã€ããã匟åã«ã€ããŠããæ·±ãç¥ãããæ¹ã¯è匟åã±ã¢ã¬ã€ããåãããŠãåç §ãã ããã
6. å®å šåºæºãšæ³šæäºé
ã»ãããç·ã«é¢ããæœè¡ã¯çš®é¡ã倿§ã§ãããã©ã®æ¹åæ§ã«ãããŠãå ±éããŠå®ãã¹ãå®å šåºæºããããŸãããã®ç¹ã¯äºåã«ãŠã³ã»ãªã³ã°ã§å¿ ãäžç·ã«ç¢ºèªããŸãã
æœè¡åã«å¿ ããç¥ããããã ãããäºé
- åŠåš ã»æä¹³ã®æç¡ïŒãäºå®ãããå ŽåãïŒ
- æçšäžã®è¬ïŒãšãã«æååºè¬ã»æè¡å°æ¿è¬ã»å ç«æå¶è¬ïŒ
- ã¢ã¬ã«ã®ãŒã®æ¢åŸïŒãšãã«ãªãã«ã€ã³ãªã©ã®éº»é æåïŒ
- æŽ»åæ§ææçã»èªå·±å ç«çŸæ£ã®æ¢åŸ
- æè¿åããä»ã®æœè¡ïŒã€ã³ã¿ãŒãã«èª¿æŽãå¿ èŠãªå ŽåããããŸãïŒ
æœè¡åŸã«æ³šæããŠããã ãããç¹
- äžæçãªæµ®è «ã»çºèµ€ã»å åºè¡ãªã©ã¯å人差ããããŸã
- ãŸãã«ææã»ã¢ã¬ã«ã®ãŒåå¿ã»çµç¯ããã£ã©ãŒã®å Žåã¯è¡ç®¡é¢é£ã®å䜵çãçããããšããããŸãã®ã§ãç°åžžåå¿ããã£ãå Žåã¯ãã ã¡ã«Celliniqueãžãé£çµ¡ãã ãã
- å€éã»äŒæ¥ã«åŒ·ãæµ®è «ã»çŒçã»èŠéç°åžžã»ç®èè²ã®å€åãªã©ãããå Žåã¯ã119çªãŸãã¯æå¯ãã®ææ¥å€æ¥ããå©çšãã ãã
7. Celliniqueã®ã»ãããç·ã«ãŠã³ã»ãªã³ã°ã«ã€ããŠ
CelliniqueïŒã»ãªããã¯å»é¢ïŒã¯ãæ±ååºå³¶å±±å€§è·¯ïŒããµã³ããïŒã«äœçœ®ããã¢ã³ããšã€ãžã³ã°ç®èç§ã¯ãªããã¯ã§ããã»ãããç·ã®ããã«è€æ°ã®åå ãéãªãé åã§ã¯ãäžã€ã®æœè¡ã®æåãããåå ãæ£ç¢ºã«åããŠããã«åãããŠèšèšããããã»ã¹ãããéèŠã«ãªãããšãå€ãã§ãã
ãã®ããCelliniqueã§ã¯ãéå¥å®é¢é·ãååã«ãŠã³ã»ãªã³ã°ããæœè¡ã»ã¢ãã¿ãŒãã©ããŒãŸã§çŽæ¥æ åœããäœå¶ã§éå¶ããŠããŸããåãæ åœå»åž«ãäžè²«ããŠã客æ§ã®å€åã远ãããšã§ã次åã®æœè¡ãçµã¿åããã®èšèšãèªç¶ã«ã€ãªãããŸããæ±å島山倧路ãšããç«å°ãããã«ãŠã³ã»ãªã³ã°åŸã®åæ¥é¢ã»ã¢ãã¿ãŒãã©ããŒããããããšããç¹ããç¶ç¶çãªã±ã¢ãå¿ èŠãªã»ãããç·ã®é åã§ã¯å©ç¹ãšãªã£ãŠããŸãã
ããããã質åïŒFAQïŒ
Q1. ã»ãããç·ãå®å šã«ãªããããšã¯ã§ããŸããïŒ
å 霢ã«äŒŽãèªç¶ãªæ§é å€åãã®ãã®ããå®å šã«ãªããããšãäŒãããããšã¯é£ããç¶æ³ã§ãããã ããåå ïŒããªã¥ãŒã ã®åªå€±ã»åãäžããã»ã³ã©ãŒã²ã³ãªã©ïŒãåããŠæŽçããããããã«åã£ãæ¹æ³ãçµã¿åãããããšã§ãã·ã¯ãæ·±ãèŠããçšåºŠãäœæãžã®ã¢ãããŒãã¯å¯èœã§ãã广ã«ã¯å人差ã倧ãããåäžã®çµæãä¿èšŒããããšã¯ã§ããŸããã
Q2. ã»ãããç·ã«ã¯å¿ ããã£ã©ãŒãæåã§ããïŒ
ããã§ã¯ãããŸããããã£ã©ãŒïŒãã¢ã«ãã³é žïŒã¯å€±ãããããªã¥ãŒã ã®è£å©ã«é¢ããç ç©¶ãè±å¯ãªéžæè¢ã§ãããåãäžããã倧ããæ¹ãèã®ãã¡ã»ã³ã©ãŒã²ã³ãå ã«æ°ã«ãªãæ¹ã«ã¯åããªãããšããããŸããåå ã«å¿ããŠã³ã©ãŒã²ã³åºæ¿ã»ã¹ãã³ããŒã¹ã¿ãŒã»ãªããã£ã³ã°ã®æ¹åæ§ãšçµã¿åãããã®ãäžè¬çã§ããäž»ãªåå ã¯äºåã«ãŠã³ã»ãªã³ã°ã§äžç·ã«åºå¥ããŸãã
Q3. ãã£ã©ãŒã¯ã©ã®ãããæç¶ããŸããïŒ
æç¶æéã¯è£œåã»æ³šå ¥éã»éšäœã»å人ã®ç¶æ ã«ãã£ãŠå€§ããç°ãªããããäžåŸã«ãäœã¶æããšæèšããããšã¯é£ããç¶æ³ã§ããèšåºç ç©¶ã§ã¯24ã¶ææç¹ãŸã§å¹æãè©äŸ¡ããäºäŸããããŸãããããã¯å人ã«ãã£ãŠç°ãªããŸããæ£ç¢ºãªãæ¡å ã¯äºåã«ãŠã³ã»ãªã³ã°ã§ãæ¬äººã®ç¶æ ã確èªããããã§äžç·ã«æŽçããŸãã
Q4. æœè¡ãããšããã«å€åãçŸããŸããïŒ
æ¹åæ§ã«ãã£ãŠç°ãªããŸãããã£ã©ãŒã®ããã«ããªã¥ãŒã ãè£ãã¢ãããŒãã¯æ¯èŒçæ©æã«å€åãæããããšããããŸãããã³ã©ãŒã²ã³åºæ¿ã®æ¹åæ§ïŒãžã¥ãã«ãã¯çïŒã¯æéããããŠæ®µéçã«äœæããçµæã§ãããæ©æã®å€åããšãåå°ãæŽããé·æç®¡çãã®ã©ã¡ãã«éç¹ã眮ããã«ãã£ãŠãåãéžæè¢ãå€ãããŸãã
Q5. å¯äœçšããªã¹ã¯ã¯ãããŸããïŒ
å¯äœçšããŸã£ãããªãæœè¡ã¯ãããŸãããäžæçãªæµ®è «ã»çºèµ€ã»å åºè¡ã¯å人差ãããããŸãã«ææã»ã¢ã¬ã«ã®ãŒã»çµç¯ããã£ã©ãŒã®å Žåã¯è¡ç®¡é¢é£ã®å䜵çã®å¯èœæ§ããããŸãããã®ããäºåã«ãŠã³ã»ãªã³ã°ã§æ¢åŸæŽã»æçšè¬ã»ã¢ã¬ã«ã®ãŒãæ£ç¢ºã«ç¢ºèªããç°åžžåå¿æã®å¯Ÿå¿åºæºãäžç·ã«ãæ¡å ããŸãã
Q6. ã«ãŠã³ã»ãªã³ã°ã ãåããããšã¯ã§ããŸããïŒ
ãã¡ããã§ããã»ãããç·ã¯åå ãæŽçããããšãã管çãå§ãŸããŸãã®ã§ãã«ãŠã³ã»ãªã³ã°ã§ãèªèº«ã®ç¶æ ãšæ¹åæ§ã確èªããã ãã§ãææçŸ©ã§ããæœè¡å®æœã®æç¡ã«ããããããã«ãŠã³ã»ãªã³ã°ã®ã¿ããåžæã®æ¹ã¯ 02-6203-3434 ãŸãã¯ã«ã«ãªããŒã¯ãããæ°è»œã«ãåãåãããã ãããïŒã«ãŠã³ã»ãªã³ã°è²»çšã«ã€ããŠã¯ããåãåããæã«ããããŠãæ¡å ããŸããïŒ
ãŸãšã
ã»ãããç·ã®ã±ã¢ã¯ããã©ã®æœè¡ãäžçªããããããå§ãŸãã®ã§ã¯ãªãããç§ã®ã»ãããç·ã¯ã©ã®åå ã倧ããã®ããããå§ãŸããŸããããªã¥ãŒã ã®åªå€±ãªã®ããåãäžãããªã®ããèã®ãã¡ã»ã³ã©ãŒã²ã³ãªã®ããå ã«åºå¥ããããšã§ãåããŠåã£ãæ¹åæ§ãèŠããŠããŸãããã®åºæºãèŠã€ããäœæ¥ã¯ãæçµçã«äºåã«ãŠã³ã»ãªã³ã°ã§äžç·ã«æŽçããããã®ã§ãã
CelliniqueïŒã»ãªããã¯å»é¢ãæ±å島山倧路ïŒã§ã¯ãéå¥å®é¢é·ãååã«ãŠã³ã»ãªã³ã°ããæœè¡ã»ã¢ãã¿ãŒãã©ããŒãŸã§çŽæ¥æ åœããŠããŸããã»ãããç·ãã©ã®ããã«è§£æ±ºããã°ããããšãæ©ã¿ã®æ¹ã¯ããæ°è»œã«ã«ãŠã³ã»ãªã³ã°ããç³ã蟌ã¿ãã ããã
æ¬ã³ã³ãã³ãã¯äžè¬çãªå¥åº·æ å ±ã®æäŸãç®çãšããŠãããå人ã®èšºæã»æ²»çã«ã€ããŠã¯å¿ ãå°éå»ã«ãçžè«ãã ãããçµæã»æç¶æ§ã»é©åæ§ã¯å人ã®èç¶æ ã»å¹Žéœ¢ã»ç掻ãã¿ãŒã³ã«ãã£ãŠç°ãªããåäžã®çµæãä¿èšŒããããšã¯ã§ããŸãããæœè¡ã«ã¯äžæçãªçŽ æã»æµ®è «ãªã©ã®å¯äœçšã®å¯èœæ§ããããçŠå¿äºé ãããå ŽåããããŸãã®ã§ãäºåã«ãŠã³ã»ãªã³ã°ã«ãŠã確èªãã ããã
â ãã¡ã¯ããã§ãã¯å®äºã¬ããŒã
æ¬èšäºã®å»çæ å ±ã¯ä»¥äžã®åºå žã«åºã¥ããŠæ€èšŒããŠããŸãïŒ
1. Aesthetic Surgery Journal Open Forum 2025 (PMC12322485) â ã»ãããç·ã®è©³çްã¡ã«ããºã ïŒçç®ã³ã©ãŒã²ã³ã»ç®èã®åã¿ã®æžå°ãäžé¡é¢èèªå±€ã®åãäžãããäžé¡éªšåžåïŒãšå¹Žéœ¢å¥å€åïŒ20代ã»30代ã§çºã®é·ãçŽ2.81åã®å·®ïŒ · pubmed.ncbi.nlm.nih.gov
2. Aesthetic Plastic Surgery 2018 (PMID 29740661) â ã»ãããç·HAãã£ã©ãŒã®ã·ã¹ãããã£ãã¯ã¬ãã¥ãŒã»ã¡ã¿åæïŒ12 RCTã»908åïŒãç¯æ£å¹æã»å®å šæ§ããªãã«ã€ã³é åã«ããçŒçè»œæž Â· pubmed.ncbi.nlm.nih.gov
3. éåœé£åå»è¬åå®å šåŠïŒMFDSïŒÂ· CE · ãã€ã ã°ããŒãã«ïŒVaim GlobalïŒ â ãžã¥ãã«ã㯠PDLLAïŒéæ¶æ©HAãçµç¹ä¿®åŸ©çšçäœææã®åœå èš±å¯ã»CEïŒç±³åœFDAæªæ¿èªïŒ · nedrug.mfds.go.kr
4. éåœé£åå»è¬åå®å šåŠïŒMFDSïŒå»çæ©åšåç®èš±å¯ â ãªãžã¥ã©ã³PNïŒãµãŒã¢ã³DNAç±æ¥ïŒ20mg/mLãèš±å¯çªå·14-825ïŒ2014幎ããããªãµãŒããPharmaResearchïŒ Â· nedrug.mfds.go.kräž»ãªæ€èšŒé ç®ïŒâ ã»ãããç·ã®å€å±€ã¡ã«ããºã ïŒçç®ã»èèªã»éªšæ ŒïŒ â HAãã£ã©ãŒã®å¹æã»å®å šæ§ïŒã¡ã¿åæïŒ â ãžã¥ãã«ãã¯ã®æåã»èš±å¯ç¯å²ïŒFDAæªæ¿èªæç€ºïŒ â ãªãžã¥ã©ã³ã®æåã»èš±å¯ â å人差ã»å¯äœçšã®æç€ºãæç¶æéã»å¹æã¯ä¿å®çãªè¡šçŸãšãããå®å šã«ãªãããã»FDAæ¿èªçã¯æèšããŠããŸããã



